Rolf Andrew Ramelmeier is EVP, Technical Operations of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 171,467 shares of SGMO, which is worth approximately $322,357. The most recent transaction as insider was on May 25, 2023, when has been sold 1,750 shares (Common Stock) at a price of $1.33 per share, resulting in proceeds of $2,327. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 171K
0% 3M change
0% 12M change
Total Value Held $322,357

Rolf Andrew Ramelmeier Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2023
SELL
Payment of exercise price or tax liability
$2,327 $1.33 p/Share
1,750 Reduced 1.01%
171,467 Common Stock
Feb 25 2023
SELL
Payment of exercise price or tax liability
$41,543 $2.66 p/Share
15,618 Reduced 8.27%
173,217 Common Stock
Feb 24 2023
BUY
Grant, award, or other acquisition
-
45,000 Added 19.24%
188,835 Common Stock
Feb 25 2022
SELL
Payment of exercise price or tax liability
$73,089 $5.9 p/Share
12,388 Reduced 12.29%
88,429 Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
-
54,000 Added 27.49%
142,429 Common Stock
Feb 25 2021
SELL
Payment of exercise price or tax liability
$87,047 $11.19 p/Share
7,779 Reduced 11.79%
58,199 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
40,000 Added 28.94%
98,199 Common Stock
Dec 31 2020
SELL
Open market or private sale
$41,247 $16.74 p/Share
2,464 Reduced 3.6%
65,978 Common Stock
Dec 24 2020
SELL
Open market or private sale
$60,391 $18.13 p/Share
3,331 Reduced 4.64%
68,442 Common Stock
RAR

Rolf Andrew Ramelmeier

EVP, Technical Operations
Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO